valprooyl oligopeptide-33 hamilelikte güvenli mi?
I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
Related ingredients
Frequently asked questions
- valprooyl oligopeptide-33 hamilelikte güvenli mi?
- I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
- valprooyl oligopeptide-33 emzirirken güvenli mi?
- No data located in the referenced authoritative sources for breastfeeding-specific effects of 'valprooyl oligopeptide-33'. In absence of documented systemic absorption or reproductive/breastfeeding data, default hazard/exposure scores remain 0. If the ingredient were to liberate valproic acid systemically, breastfeeding concerns would follow those for valproate, but that linkage is not established here.
- valprooyl oligopeptide-33 bebek cildi için güvenli mi?
- No specific data for infants (0–3 yr) were found. By default there is no evidence of hazard or mechanism for this ingredient. Because infant skin has higher absorption potential for ingredients that are measurably absorbed in adults, I assign a conservative exposure increase of +1 only if the ingredient has any measurable dermal absorption; however, no data confirming adult absorption were located for this specific ingredient.
- VeriMom valprooyl oligopeptide-33 nasıl puanlıyor?
- VeriMom valprooyl oligopeptide-33'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte valprooyl oligopeptide-33 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.